NYU Langone Health: Alcoholism trials

The registry lists 12 Alcoholism studies with NYU Langone Health as lead sponsor. 2 are open to participants now and 7 have results posted.

Phase 1 2Phase 2 5Phase 4 3No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Neurobehavioral Mechanisms of Psilocybin-assisted Treatment for AUDRecruitingNCT06349083Phase 2
• Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSDRecruitingNCT03667846Phase 2
• Effects of Cannabidiol in Alcohol Use DisorderCompletedNCT03252756Phase 1/2Results posted
• Cannabidiol as a Treatment for AUD Comorbid With PTSDCompletedNCT03248167Phase 1/2Results posted
• Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department UsersCompletedNCT02445339Phase 4Results posted
• A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceCompletedNCT02061293Phase 2Results posted
• Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary CareCompletedNCT01893827Phase 4Results posted
• Impact of Exercise and Affirmations (IntenSati) on Addiction-related Cognitive and Psychosocial DeficitsCompletedNCT01171677Not applicableResults posted
• Extended-release Naltrexone for Alcohol Dependence in Primary CareCompletedNCT00620750Phase 4Results posted
• Mortality Reductions Based on AUD/Heavy Alcohol Use, HIV Risk, and Cardiovascular RiskActive, not recruitingNCT05828849Not applicable
• Black Church Treatment StudyActive, not recruitingNCT04580810Not applicable
• Project ACTIVE a Clinical InterventionCompletedNCT04211883Not applicable